Evidence map›Paper›PMID 32768490›Full record

ReviewVirus research2020

Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.

Kobra Bahrampour Juybari, Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Karim Hemati, Saeed Mehrzadi

Open access · greenAbstract readReview
In one paragraph

Review in Virus research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Acute myocarditis and low melatonin: unraveling a potential link.Frontiers in cardiovascular medicine · 2025
    Article
  10. Article
  11. Melatonin's Impact on Wound Healing.Antioxidants (Basel, Switzerland) · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kobra Bahrampour JuybariDepartment of Pharmacology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Mohammad Hossein PourhanifehRazi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
Azam HosseinzadehRazi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
Karim HematiDepartment of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
Saeed MehrzadiRazi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: mehrzadi.s@iums.ac.ir.
Iran University of Medical Sciences · IRSemnan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections are dangerous diseases for human health worldwide, which lead to significant morbidity and mortality each year. Because of their importance and the lack of effective therapeutic approaches, further attempts should be made to discover appropriate alternative or complementary treatments. Melatonin, a multifunctional neurohormone mainly synthesized and secreted by the pineal gland, plays some roles in the treatment of viral infections. Regarding a deadly outbreak of COVID-19 across the world, we decided to discuss melatonin functions against various viral infections including COVID-19. Therefore, in this review, we summarize current evidence on melatonin therapy for viral infections with focus on possible underlying mechanisms of melatonin actions.

Indexed as

AntioxidantsAntiviral AgentsBetacoronavirusCoronavirus InfectionsCOVID-19Host-Pathogen InteractionsHumansMelatoninOxidative StressPandemicsPneumonia, ViralSARS-CoV-2Signal TransductionVaccinationViral VaccinesVirus DiseasesAntioxidantsAntiviral AgentsMelatoninViral VaccinesApoptosisCoronavirusCovid-19InflammationMelatoninOxidative stressRespiratory syncytial virusStem cellVenezuelan equine encephalitis virusViral hepatitisViral infectionsViral myocarditis

Identifiers

PMID32768490
PMCPMC7405774
OpenAlexW3047427701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.